drugset / Trial / NCT03828084
Randomized, Single-dose, Crossover Study of 4 Decitabine and Tetrahydrouridine (EPI01) Formulations in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
To study the pharmacokinetic profiles of decitabine and tetrahydrouridine (THU) from 3 modified release formulations in healthy subjects.
Timeline
- Start
- 2019-04-03
- Primary completion
- 2019-05-02
- Completion
- 2019-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 15 mg | Oral |
| Subject | Tetrahydrouridine | Small molecule | 750 mg | Oral |
Indications
No indication recorded.